Burnham Institute for Medical Research Appoints Daniel P. Kelly, M.D. as Scientific...

Burnham Institute for Medical Research Appoints Daniel P. Kelly, M.D. as Scientific Director for Florida Campus

ORLANDO, Fla.--(Business Wire)--
Burnham Institute for Medical Research (Burnham) today announced
that Daniel P. Kelly, M.D. will assume the position of Scientific
Director of Burnham at Lake Nona in Orlando, Florida. In that capacity
he will guide the scientific direction of Burnham's Orlando facility
by forming several research programs related to diabetes, obesity,
metabolism and heart disease. In addition, Dr. Kelly will be
responsible for faculty recruitment for the Orlando site, which is
situated in Lake Nona's "medical city," a newly developed science and
technology park with several university and clinical partners.

"I was attracted by the excitement of building a unique
world-class research effort focused on the immense problem of diabetes
and its complications," said Dr. Kelly. "The power of
interdisciplinary research can be harnessed in a single institute by
bringing together scientists across many different fields. I look
forward to assembling a team that capitalizes on the current strengths
of the Burnham organization, while adding talented new scientists that
drive our research mission forward. Linking discovery science to
health care delivery by working with our clinical partners in the
context of the developing medical city will change the future of
health care."

Dr. Kelly will officially join Burnham on July 1, 2008. He is
currently the Tobias and Hortense Lewin Professor, Director of the
Center for Cardiovascular Research, and Chief of the Cardiovascular
Division in the Department of Medicine at Washington University School
of Medicine in St. Louis, Missouri. Dr. Kelly joined the Washington
University School of Medicine faculty in 1989 after obtaining his M.D.
from the University of Illinois College of Medicine in Chicago in 1982
and completing a medicine residency followed by Postdoctoral
Fellowships in the Biological Chemistry and Clinical Cardiology
departments at Washington University School of Medicine. He moved up
the ranks from Instructor of Medicine to tenured Professor of
Medicine, Molecular Biology and Pharmacology, and Pediatrics at
Washington University.

Dr. Kelly's scientific interests include fundamental and
translational research in cellular energy metabolism relevant to
common diseases such as heart failure and diabetes, especially
diabetic heart disease. He is the author of more than 100
peer-reviewed original research papers focusing on these areas.

"We are proud that Dr. Kelly is joining the Burnham team to lead
expansion of our medical research programs in Florida, and to launch a
new research center devoted to diabetes and obesity research," said
John C. Reed, M.D., Ph.D., President and CEO, Professor and Donald
Bren Presidential Chair. "Our organization and our collaborators will
benefit significantly from Dr. Kelly's scientific vision, impressive
leadership qualities and strong track record of success in building
world-class research programs."

About Burnham Institute for Medical Research

Burnham Institute for Medical Research conducts world-class
collaborative research dedicated to finding cures for human disease,
improving quality of life, and thus creating a legacy for its
employees, donors, and community. The Institute is headquartered in La
Jolla, CA where it was established as a nonprofit, public benefit
corporation in 1976 and is now home to four major centers: a National
Cancer Institute-designated Cancer Center; the Del E. Webb Center for
Neurosciences, Aging and Stem Cell Research; the Infectious and
Inflammatory Disease Center; and the Sanford Children's Health
Research Center. In 2006, Burnham established a center for
bionanotechnology research at the University of California, Santa
Barbara. Burnham is currently establishing a campus at Lake Nona in
Orlando, Florida that will focus on diabetes and obesity research and
will expand the Institute's drug discovery capabilities. Today,
Burnham employs more than 800 people and ranks consistently among the
world's top 25 organizations for its research impact and among the top
four research institutes nationally for NIH grant funding. For
additional information about Burnham and to learn about ways to
support its research, visit www.burnham.org.

Burnham Institute for Medical Research
Shannon Lovejoy, Communications Manager
858-795-5233
slovejoy@burnham.org

Copyright Business Wire 2008